Driven by the goal of making a positive societal impact through entrepreneurship, Lars joined NLC after finishing my master’s degree at the London School of Economics. Together with the rest of the Venture Finance team, he is responsible for designing and validating business models of our new healthtech ventures, managing financing rounds for ventures in the NLC portfolio (both dilutive and non-dilutive), and developing novel financial propositions to ensure all our portfolio companies are financed according to need. This is all done with one single goal in mind: to accelerate the growth of NLC’s venture portfolio and bring more groundbreaking medical innovations to the patient.